Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Novel combinations using pemetrexed in malignant mesothelioma.

Gadgeel SM, Pass HI.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. Review.

PMID:
15117427
2.

Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.

Suwanrusme H, Meyer ML, Green MR.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. Review.

PMID:
15117426
3.

Pemetrexed-cisplatin combination in mesothelioma.

Reck M, Gatzemeier U.

Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. Review.

PMID:
15877521
4.

Current chemotherapeutic treatment of malignant pleural mesothelioma.

Nowak AK, Byrne MJ, Millward MJ, Alvarez JM, Robinson BW.

Expert Opin Pharmacother. 2004 Dec;5(12):2441-9. Review.

PMID:
15571462
5.

Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.

Green J, Dundar Y, Dodd S, Dickson R, Walley T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005574. Review.

PMID:
17253564
6.

The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

Fizazi K, John WJ, Vogelzang NJ.

Semin Oncol. 2002 Feb;29(1):77-81. Review.

PMID:
11836672
7.

Chemotherapy options and new advances in malignant pleural mesothelioma.

Steele JP, Klabatsa A.

Ann Oncol. 2005 Mar;16(3):345-51. Review.

8.

[Malignant pleural mesothelioma].

Nishiwaki Y.

Gan To Kagaku Ryoho. 2003 May;30(5):589-94. Review. Japanese.

PMID:
12795087
9.

Pemetrexed: a multitargeted antifolate.

Rollins KD, Lindley C.

Clin Ther. 2005 Sep;27(9):1343-82. Review.

PMID:
16291410
10.

Second-line treatment for malignant pleural mesothelioma.

Ceresoli GL, Zucali PA, Gianoncelli L, Lorenzi E, Santoro A.

Cancer Treat Rev. 2010 Feb;36(1):24-32. doi: 10.1016/j.ctrv.2009.09.003. Review.

PMID:
19879055
11.

Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.

Budde LS, Hanna NH.

Expert Rev Anticancer Ther. 2004 Jun;4(3):361-8. Review.

PMID:
15161435
12.
13.

Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.

Manegold C.

Semin Oncol. 2003 Aug;30(4 Suppl 10):32-6. Review.

PMID:
12917819
14.

[Chemotherapy of malignant pleural mesothelioma: have we made any progress?].

Reck M, Heigener DF, Gatzemeier U.

Zentralbl Chir. 2008 Jun;133(3):238-42. doi: 10.1055/s-2008-1004809. Review. German.

PMID:
18563688
15.

An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.

Zilembo N, Vitali M, Pietrantonio F, Platania M, Del Vecchio M, Bajetta E.

Tumori. 2010 Nov-Dec;96(6):1031-4. Review.

16.

Pemetrexed for diffuse malignant pleural mesothelioma.

Manegold C, Aisner J.

Semin Oncol. 2002 Apr;29(2 Suppl 5):30-5. Review.

PMID:
12023790
17.

Systemic chemotherapy in the management of malignant peritoneal mesothelioma.

Garcia-Carbonero R, Paz-Ares L.

Eur J Surg Oncol. 2006 Aug;32(6):676-81. Review.

PMID:
16616827
18.
19.

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.

Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care..

J Thorac Oncol. 2006 Jul;1(6):591-601. Review.

20.

Alimta (pemetrexed disodium): a multitargeted antifolate for the treatment of mesothelioma.

Green MR.

Lung Cancer. 2002 Nov;38 Suppl 2:S55-7. Review.

PMID:
12431831
Items per page

Supplemental Content

Support Center